Danish Pharmacovigilance Update, 21 February 2011

In this issue of Danish Pharmacovigilance Update:

• Risk of severe liver injury with Multaq®
• Risk of eosinophilic pneumonia with daptomycin (Cubicin®)
• New study from Finland raises suspicion of increased risk of narcolepsy from the influenza vaccine Pandemrix®
• Problems with peritoneal dialysis solutions from Baxter A/S persist
• Insulin products and the risk of heart failure from concomitant use of pioglitazone (Actos®)
• New e-forms for reporting adverse drug reactions (ADRs) in Denmark

Download the newsletter in the box to the right.